Recovery from Liver Failure after Hepatectomy for Hepatocellular Carcinoma in Cirrhosis: Meaning of the Model for End-Stage Liver Disease
- 30 November 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 203 (5), 670-676
- https://doi.org/10.1016/j.jamcollsurg.2006.06.018
Abstract
Background Hepatectomy for hepatocellular carcinoma in cirrhosis is followed by an impairment of liver function that can lead to patient death. The model for end-stage liver disease (MELD) is considered an index of hepatic functional reserve, and its assessment on postoperative course may properly identify individuals at risk of liver failure. Study design Two hundred hepatectomies for hepatocellular carcinoma in cirrhosis were reviewed. Irreversible postoperative liver failure was defined as an impairment of liver function after hepatectomy that led to patient death or required transplantation. The MELD scores at postoperative days (POD) 1, 3, 5, and 7 were calculated and kinetics of changes investigated with t-test; logistic regression was applied to identify predictive variables of postoperative liver failure. Results Kinetics of postoperative MELD score showed an impairment of liver function between PODs 1 and 3; 185 patients in whom postoperative liver failure did not develop showed a considerable decrease in MELD score between PODs 3 and 5 (11.9±2.8 and 10.6±2.4, respectively, p < 0.001). On the contrary, 15 patients, who experienced the event, showed an increase in MELD score between PODs 3 and 5 (18.2±3.9 and 18.3±3.6, respectively; p=0.845). Multivariate analysis showed preoperative MELD score (p < 0.001), major hepatectomy (p=0.028), and MELD score increase between PODs 3 and 5 (p=0.011) as independent predictors of irreversible postoperative liver failure. Scores are reported as mean ± SD. Conclusions Recovery from liver impairment after hepatectomy for hepatocellular carcinoma in cirrhosis starts from POD 3; MELD scores increasing between PODs 3 and 5 may identify patients at risk of liver failure and represents the trigger for beginning intensive treatment or evaluating salvage transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Extended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified?Annals of Surgery, 2002
- Preoperative Galactose Elimination Capacity Predicts Complications and Survival After Hepatic ResectionAnnals of Surgery, 2002
- Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added ValueAnnals of Surgery, 2001
- The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgerySurgery, 2000
- Hepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital DeathsAnnals of Surgery, 1999
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Early hepatocellular carcinoma as an entity with a high rate of surgical cureHepatology, 1998
- Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomyBritish Journal of Surgery, 1997
- Criteria for safe hepatic resectionThe American Journal of Surgery, 1995
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973